TGF-β1 elevates P-gp and BCRP in hepatocellular carcinoma through HOTAIR/miR-145 axis.


Journal

Biopharmaceutics & drug disposition
ISSN: 1099-081X
Titre abrégé: Biopharm Drug Dispos
Pays: England
ID NLM: 7911226

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 25 10 2018
revised: 13 01 2019
accepted: 23 01 2019
pubmed: 31 1 2019
medline: 15 6 2019
entrez: 31 1 2019
Statut: ppublish

Résumé

Multidrug resistance (MDR) is common in patients and has been linked to transforming growth factor-β1 (TGF-β1) and overexpression of drug efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), although the molecular mechanisms remain largely unknown. This study aimed to investigate the mechanisms underlying TGF-β1-induced MDR in hepatocellular carcinoma (HCC) cells. It was found that TGF-β1 upregulated HOX transcript antisense RNA (HOTAIR) expression in HCC cells. When drosophila mothers against decapentaplegic 4 (SMAD4) was silenced, HOTAIR expression was accordingly reduced. Meanwhile, miR-145 expression was increased in the case HOTAIR was silenced. If the enhancer of zeste homolog 2 (EZH2) was knocked down using small interfering RNA (siRNA), miR-145 expression was decreased. Then, the regulatory role of miR-145 in P-gp and BCRP expression was explored. The results showed that the expression of P-gp and BCRP protein was suppressed by miR-145 through binding to the 3'-untranslated regions (3'-UTRs) of P-gp and BCRP. In conclusion, our study revealed a novel mechanism explaining TGF-β1-induced MDR in HCC through upregulating P-gp and BCRP via the SMAD4/HOTAIR/miR-145 axis.

Identifiants

pubmed: 30698830
doi: 10.1002/bdd.2172
doi:

Substances chimiques

ABCG2 protein, human 0
ATP Binding Cassette Transporter, Subfamily B, Member 1 0
ATP Binding Cassette Transporter, Subfamily G, Member 2 0
HOTAIR long untranslated RNA, human 0
MIRN145 microRNA, human 0
MicroRNAs 0
Neoplasm Proteins 0
RNA, Long Noncoding 0
Transforming Growth Factor beta1 0
Imatinib Mesylate 8A1O1M485B

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-80

Subventions

Organisme : The National Natural Science Foundation of China
ID : 81773044
Organisme : The National Natural Science Foundation of China
ID : 81270031
Organisme : The National Natural Science Foundation of China
ID : 81272737
Organisme : The National Natural Science Foundation of China
ID : 81372375
Organisme : The National Natural Science Foundation of China
ID : 81473278

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Jiehong Kong (J)

Center for Drug Metabolism and Pharmacokinetics, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Yajing Qiu (Y)

Center for Drug Metabolism and Pharmacokinetics, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Yuan Li (Y)

Center for Drug Metabolism and Pharmacokinetics, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Hongjian Zhang (H)

Center for Drug Metabolism and Pharmacokinetics, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Weipeng Wang (W)

Center for Drug Metabolism and Pharmacokinetics, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH